Prediction of intestinal permeability.
暂无分享,去创建一个
[1] Pravin Chaturvedi,et al. Design principles for orally bioavailable drugs , 1996 .
[2] K. Luthman,et al. Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.
[3] M Zschiesche,et al. Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P‐glycoprotein , 2000, Clinical pharmacology and therapeutics.
[4] M Pastor,et al. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[5] W. Rubas,et al. Comparison of the Permeability Characteristics of a Human Colonic Epithelial (Caco-2) Cell Line to Colon of Rabbit, Monkey, and Dog Intestine and Human Drug Absorption , 2004, Pharmaceutical Research.
[6] S. Singer,et al. The Fluid Mosaic Model of the Structure of Cell Membranes , 1972, Science.
[7] U Norinder,et al. Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] William G. Cochran,et al. Experimental Designs, 2nd Edition , 1950 .
[9] James W. McFarland,et al. Quantitative Estimation of Drug Absorption in Humans for Passively Transported Compounds on the Basis of Their Physico‐chemical Parameters , 2000 .
[10] H. van de Waterbeemd,et al. Property-based design: optimization of drug absorption and pharmacokinetics. , 2001, Journal of medicinal chemistry.
[11] T I Oprea,et al. Toward minimalistic modeling of oral drug absorption. , 1999, Journal of molecular graphics & modelling.
[12] P. Labute. A widely applicable set of descriptors. , 2000, Journal of molecular graphics & modelling.
[13] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[14] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[15] U Norinder,et al. Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[16] Hamish Ryder,et al. Prediction of Drug Permeability Based on Grid Calculations , 1999 .
[17] S. Krämer,et al. Absorption prediction from physicochemical parameters. , 1999, Pharmaceutical science & technology today.
[18] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[19] B. Müller,et al. Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption , 1999, Pharmaceutical Research.
[20] Y. Martin,et al. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry. , 1981, Journal of medicinal chemistry.
[21] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .
[22] Ulf Norinder,et al. Theoretical Calculation and Prediction of Caco-2 Cell Permeability Using MolSurf Parametrization and PLS Statistics , 1997, Pharmaceutical Research.
[23] O. H. Chan,et al. Discrimination between drug candidates using models for evaluation of intestinal absorption , 1997 .
[24] Peter J. Rousseeuw,et al. Robust regression and outlier detection , 1987 .
[25] G Camenisch,et al. Cell permeability as a parameter for lead generation in the protein Tyrosine kinase inhibition field. , 2001, Bioorganic & medicinal chemistry letters.
[26] H Lennernäs,et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.
[27] P. Arnaud,et al. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. , 2001, Journal of pharmaceutical sciences.
[28] Satinder Ahuja,et al. Handbook of modern pharmaceutical analysis , 2001 .
[29] D. Scherman,et al. High lipophilicity decreases drug transport across intestinal epithelial cells. , 1994, The Journal of pharmacology and experimental therapeutics.
[30] S. Morgan,et al. Outlier detection in multivariate analytical chemical data. , 1998, Analytical chemistry.
[31] M. Kool,et al. A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.
[32] A. Leo,et al. Partition coefficients and their uses , 1971 .
[33] D. E. Clark. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.
[34] G Folkers,et al. Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.
[35] Hans Lennernäs,et al. Intestinal Permeability: Prediction from Theory , 2000 .
[36] Akira Tsuji,et al. Carrier-Mediated Intestinal Transport of Drugs , 1996, Pharmaceutical Research.
[37] Malcolm Rowland,et al. Comparison of HT29-18-C1 and Caco-2 Cell Lines as Models for Studying Intestinal Paracellular Drug Absorption , 1996, Pharmaceutical Research.
[38] Jacob Cohen. Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.
[39] Pickett,et al. Computational methods for the prediction of 'drug-likeness' , 2000, Drug discovery today.
[40] K. Luthman,et al. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.
[41] Kararli Tt,et al. Gastrointestinal absorption of drugs. , 1989 .
[42] Shiyin Yee,et al. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.
[43] G Houin,et al. Gastrointestinal absorption of drugs: methods and studies , 1999, Fundamental & clinical pharmacology.
[44] M. Yazdanian,et al. Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.
[45] David E. Clark,et al. Enhancing the Hit-to-Lead Properties of Lead Optimization Libraries , 2000, J. Chem. Inf. Comput. Sci..
[46] Yi Wang,et al. Chapter 27. Ex vivo approaches to predicting oral pharmacokinetics in humans , 2000 .
[47] J. Platts,et al. Hydrogen bond structural group constants. , 2001, The Journal of organic chemistry.
[48] A. Seelig,et al. Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. , 2000, International journal of clinical pharmacology and therapeutics.
[49] R T Borchardt,et al. Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayers. , 2001, Current protocols in pharmacology.
[50] A. Berglund,et al. Structure-property model for membrane partitioning of oligopeptides. , 2000, Journal of medicinal chemistry.
[51] J. S. Hunter,et al. Statistics for experimenters : an introduction to design, data analysis, and model building , 1979 .
[52] H Ahlbrecht,et al. Minimal Molecular Determinants of Substrates for Recognition by the Intestinal Peptide Transporter* , 1998, The Journal of Biological Chemistry.
[53] J J Baldwin,et al. Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.
[54] H Lennernäs,et al. Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models , 1997, The Journal of pharmacy and pharmacology.
[55] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[56] G Folkers,et al. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[57] Kristina Luthman,et al. Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.
[58] U Norinder,et al. Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.
[59] M H Tarbit,et al. High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds. , 1998, Current opinion in chemical biology.
[60] G Beck,et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.
[61] Peter C. Jurs,et al. Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..
[62] A. Seelig. A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.
[63] E. Wright,et al. Patterns of non-electrolyte permeability , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[64] D. Manallack,et al. Theoretical hydrogen bonding parameters for drug design. , 2001, Journal of molecular graphics & modelling.
[65] J. Tolan,et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.
[66] Kristina Luthman,et al. Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties , 1999, Pharmaceutical Research.
[67] Aalt Bast,et al. Comprehensive medicinal chemistry , 1991 .
[68] P Langguth,et al. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. , 1999, Journal of pharmaceutical sciences.
[69] D. Massart,et al. The Mahalanobis distance , 2000 .
[70] R. Mannhold,et al. Multivariate analysis of experimental and computational descriptors of molecular lipophilicity , 1998, Journal of computer-aided molecular design.
[71] J. Diamond,et al. Molecular forces governing non-electrolyte permeation through cell membranes , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[72] A. Seelig,et al. Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[73] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[74] Roger Phan-Tan-Luu,et al. Pharmaceutical Experimental Design , 1998 .
[75] Han van de Waterbeemd,et al. Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors , 1996 .
[76] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.
[77] Kenneth M. Merz,et al. Computation of the physio‐chemical properties and data mining of large molecular collections , 2002, J. Comput. Chem..
[78] M. Kataoka,et al. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[79] Y. Sugiyama,et al. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[80] Y Zhang,et al. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. , 1998, Journal of pharmaceutical sciences.
[81] U Norinder,et al. Theoretical calculation and prediction of drug transport processes using simple parameters and partial least squares projections to latent structures (PLS) statistics. The use of electrotopological state indices. , 2001, Journal of pharmaceutical sciences.
[82] John J. Baldwin,et al. 2 - Combinatorial Chemistry and High-Throughput Screening in Drug Discovery and Development , 2001 .
[83] Albert J. Leo,et al. Calculating log P(oct) with no missing fragments; The problem of estimating new interaction parameters , 2000 .
[84] A. Barve,et al. Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats , 1998, Pharmaceutical Research.
[85] C. Hansch,et al. Lipophilic character and biological activity of drugs. II. The parabolic case. , 1973, Journal of pharmaceutical sciences.
[86] P. Rousseeuw,et al. Unmasking Multivariate Outliers and Leverage Points , 1990 .
[87] D. Fleisher,et al. Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration , 1999, Clinical pharmacokinetics.
[88] Y Zhang,et al. The Gut as a Barrier to Drug Absorption , 2001, Clinical pharmacokinetics.
[89] W J Dunn,et al. Linear relationships between lipophilic character and biological activity of drugs. , 1972, Journal of pharmaceutical sciences.
[90] A. Eckert,et al. Solid-supported lipid membranes as a tool for determination of membrane affinity: high-throughput screening of a physicochemical parameter. , 2001, Journal of pharmaceutical sciences.
[91] Brahma N. Singh. Effects of Food on Clinical Pharmacokinetics , 1999, Clinical pharmacokinetics.
[92] R A Morrison,et al. Current methodologies used for evaluation of intestinal permeability and absorption. , 2000, Journal of pharmacological and toxicological methods.
[93] K Gubernator,et al. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.
[94] K. Luthman,et al. Virtual screening of intestinal drug permeability. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[95] Sietsema Wk,et al. The absolute oral bioavailability of selected drugs , 1989 .
[96] Gianpaolo Bravi,et al. Application of MS-WHIM Descriptors: 3. Prediction of Molecular Properties , 2000 .
[97] D. Shen,et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. , 1997, The Journal of pharmacology and experimental therapeutics.
[98] Kevin C. Johnson,et al. Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.
[99] B. Faller,et al. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.
[100] J. H. Kou,et al. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[101] P. Carrupt,et al. Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .
[102] K. Luthman,et al. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. , 1998, Journal of medicinal chemistry.
[103] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[104] M. Yazdanian,et al. Evaluation of an accelerated Caco-2 cell permeability model. , 2000, Journal of pharmaceutical sciences.
[105] D. E. Clark,et al. Prediction of intestinal absorption and blood-brain barrier penetration by computational methods. , 2001, Combinatorial chemistry & high throughput screening.
[106] Ulf Norinder,et al. Prediction of Polar Surface Area and Drug Transport Processes Using Simple Parameters and PLS Statistics , 2000, J. Chem. Inf. Comput. Sci..
[107] O. H. Chan,et al. Use of immobilized artificial membrane chromatography for drug transport applications. , 1998, Journal of pharmaceutical sciences.
[108] R. Welsch,et al. The Hat Matrix in Regression and ANOVA , 1978 .
[109] A. C. Rencher. Methods of multivariate analysis , 1995 .
[110] D Mackay,et al. A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol-water partitioning. , 1988, Journal of Pharmacy and Science.
[111] P. Artursson,et al. A conditionally immortalized epithelial cell line for studies of intestinal drug transport. , 1999, The Journal of pharmacology and experimental therapeutics.
[112] G Folkers,et al. Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[113] O. H. Chan,et al. Physicochemical and drug-delivery considerations for oral drug bioavailability , 1996 .
[114] A. Ghose,et al. Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods , 1998 .
[115] Vic Barnett,et al. Outliers in Statistical Data , 1980 .
[116] M. Kool,et al. The multidrug resistance protein family. , 1999, Biochimica et biophysica acta.
[117] D. Thakker,et al. Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium , 1997 .
[118] Denis M. Bayada,et al. Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.